{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:58:34Z","timestamp":1790427514341,"version":"4.1.0"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2016,4,2]]},"DOI":"10.18632\/aging.100925","type":"journal-article","created":{"date-parts":[[2016,6,4]],"date-time":"2016-06-04T01:27:55Z","timestamp":1465003675000},"page":"1102-1114","source":"Crossref","is-referenced-by-count":119,"title":["Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL\/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway"],"prefix":"10.18632","volume":"8","author":[{"given":"Zhifeng","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"},{"name":"Department of Emergency Medicine, The Yangzhou First People's Hospital, Yangzhou, Jiangsu Province 225001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijian","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyun","family":"Da","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genkai","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiu","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"},{"name":"Department of Rheumatology, Affiliated First Hospital of Xiamen University, Xiamen, Fujian Province 361000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, China"},{"name":"Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Medical College of Nantong University, Nantong, Jiangsu Province 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,2]]},"reference":[{"key":"1","first-page":"929","article-title":"Systemic lupus erythematosus","volume":"35","author":"Isenberg","year":"2008","journal-title":"The New England journal of medicine"},{"key":"2","first-page":"2073","article-title":"Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography","volume":"5","author":"Monteil","year":"1991","journal-title":"Cancer research"},{"key":"3","first-page":"3155","article-title":"B cell modulation strategies in autoimmunity: the SLE example","volume":"1","author":"Carsetti","year":"2011","journal-title":"Current pharmaceutical design"},{"key":"4","first-page":"2970","article-title":"Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment","volume":"5","author":"Jayne","year":"2006","journal-title":"Arthritis and rheumatism"},{"key":"5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.18632\/aging.100034","article-title":"Validation of anti-aging drugs by treating age-related diseases","volume":"1","author":"Blagosklonny","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"6","first-page":"327","article-title":"B-cell-depleting therapy in systemic lupus erythematosus","volume":"12","author":"Khamashta","year":"2012","journal-title":"The American journal of medicine"},{"key":"7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/hum.2010.115","article-title":"Bone marrow mesenchymal stem cells: historical overview and concepts","volume":"2","author":"Charbord","year":"2010","journal-title":"Human gene therapy"},{"key":"8","first-page":"458","article-title":"Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice","volume":"2","author":"Zhao","year":"2005","journal-title":"DNA and cell biology"},{"key":"9","first-page":"74","article-title":"Interactions between human mesenchymal stem cells and natural killer cells","volume":"2","author":"Papamichail","year":"2006","journal-title":"Stem cells"},{"key":"10","first-page":"3499","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"11","author":"Fibbe","year":"2007","journal-title":"Blood"},{"key":"11","first-page":"2114","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"10","author":"Fibbe","year":"2006","journal-title":"Blood"},{"key":"12","first-page":"4817","article-title":"Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma","volume":"10","author":"Rameshwar","year":"2006","journal-title":"Blood"},{"key":"13","first-page":"850","article-title":"Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"1","author":"Mok","year":"2010","journal-title":"Lupus"},{"key":"14","first-page":"2307","article-title":"Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients","volume":"2","author":"Cheng","year":"2012","journal-title":"Cellular signalling"},{"key":"15","first-page":"2387","article-title":"Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"2","author":"Sun","year":"2012","journal-title":"Stem cells and development"},{"key":"16","first-page":"134243","article-title":"p53\/p21 Pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients","volume":"201","author":"Cheng","year":"2013","journal-title":"Clinical & developmental immunology"},{"key":"17","first-page":"2267","article-title":"Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience","volume":"2","author":"Shi","year":"2013","journal-title":"Cell transplantation"},{"key":"18","first-page":"1421","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"2","author":"Shi","year":"2009","journal-title":"Stem cells"},{"key":"19","first-page":"1502","article-title":"Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL\/lpr mice","volume":"1","author":"Sun","year":"2010","journal-title":"Lupus"},{"key":"20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/cmi.2008.52","article-title":"Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL\/lpr mice","volume":"5","author":"Sun","year":"2008","journal-title":"Cellular & molecular immunology"},{"key":"21","first-page":"2467","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"6","author":"Hou","year":"2010","journal-title":"Arthritis and rheumatism"},{"key":"22","first-page":"142","article-title":"Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL\/lpr and (NZB\/NZW)F1 mice","volume":"14","author":"Gilkeson","year":"2012","journal-title":"Clinical immunology"},{"key":"23","first-page":"245","article-title":"Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis","volume":"2","author":"Lee","year":"2011","journal-title":"Cell transplantation"},{"key":"24","first-page":"317","article-title":"Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients","volume":"1","author":"Figueroa","year":"2010","journal-title":"Lupus"},{"key":"25","first-page":"338","article-title":"mTOR is a key modulator of ageing and age-related disease","volume":"49","author":"Kaeberlein","year":"2013","journal-title":"Nature"},{"key":"26","first-page":"263","article-title":"mTOR Signaling from Cellular Senescence to Organismal Aging","volume":"5","author":"Wei","year":"2014","journal-title":"Aging and disease"},{"key":"27","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.4161\/cc.7.21.6965","article-title":"Aging: ROS or TOR","volume":"7","author":"Blagosklonny","year":"2008","journal-title":"Cell cycle"},{"key":"28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.arr.2005.10.001","article-title":"Aging of mesenchymal stem cells","volume":"5","author":"Stolzing","year":"2006","journal-title":"Ageing research reviews"},{"key":"29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.18632\/aging.100160","article-title":"The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway","volume":"2","author":"Blagosklonny","year":"2010","journal-title":"Aging (Albany NY)"},{"key":"30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nature reviews Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"e70024","DOI":"10.1371\/journal.pone.0070024","article-title":"The PI3K\/Akt\/mTOR pathway is implicated in the premature senescence of primary human endothelial cells exposed to chronic radiation","volume":"8","author":"Tapio","year":"2013","journal-title":"PloS one"},{"key":"32","first-page":"8832","article-title":"Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program","volume":"11","author":"Blagosklonny","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"33","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.4161\/cc.7.21.6919","article-title":"Growth stimulation leads to cellular senescence when the cell cycle is blocked","volume":"7","author":"Blagosklonny","year":"2008","journal-title":"Cell cycle"},{"key":"34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.18632\/aging.100040","article-title":"Growth and aging: a common molecular mechanism","volume":"1","author":"Hall","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"35","first-page":"2256","article-title":"Inhibition of Akt\/mTOR attenuates age-related changes in mesenchymal stem cells","volume":"3","author":"Hughes","year":"2014","journal-title":"Stem cells"},{"key":"36","first-page":"89ra58","article-title":"Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells","volume":"3","author":"Collins","year":"2011","journal-title":"Science translational medicine"},{"key":"37","doi-asserted-by":"publisher","first-page":"9718","DOI":"10.18632\/oncotarget.3929","article-title":"Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats","volume":"6","author":"Chernova","year":"2015","journal-title":"Oncotarget"},{"key":"38","doi-asserted-by":"publisher","first-page":"19405","DOI":"10.18632\/oncotarget.3740","article-title":"Rejuvenating immunity: \u201canti-aging drug today\u201d eight years later","volume":"6","author":"Blagosklonny","year":"2015","journal-title":"Oncotarget"},{"key":"39","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.4161\/cc.8.12.8606","article-title":"Rapamycin decelerates cellular senescence","volume":"8","author":"Blagosklonny","year":"2009","journal-title":"Cell cycle"},{"key":"40","first-page":"5314","article-title":"Altered mTOR signaling in senescent retinal pigment epithelium","volume":"5","author":"Sternberg","year":"2010","journal-title":"Investigative ophthalmology & visual science"},{"key":"41","first-page":"2983","article-title":"Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus","volume":"5","author":"Perl","year":"2006","journal-title":"Arthritis and rheumatism"},{"key":"42","first-page":"278","article-title":"Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug","volume":"18","author":"Pestell","year":"2012","journal-title":"The American journal of pathology"},{"key":"43","first-page":"289","article-title":"Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus","volume":"3","author":"Sehgal","year":"1994","journal-title":"Arthritis and rheumatism"},{"key":"44","first-page":"105","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and\u2014yet\u2014unanswered questions","volume":"1","author":"Longhi","year":"2015","journal-title":"Autoimmunity reviews"},{"key":"45","doi-asserted-by":"publisher","first-page":"660","DOI":"10.18632\/aging.100494","article-title":"Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency","volume":"4","author":"Donehower","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.18632\/aging.100498","article-title":"Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+\/\u2212 mice","volume":"4","author":"Gudkov","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"47","first-page":"344","article-title":"Regulatory T cells in systemic lupus erythematosus","volume":"4","author":"Tenbrock","year":"2015","journal-title":"European journal of immunology"},{"key":"48","first-page":"68","article-title":"Th1\/Th17 plasticity is a marker of advanced beta cell autoimmunity and impaired glucose tolerance in humans","volume":"19","author":"Vaarala","year":"2015","journal-title":"Journal of immunology"},{"key":"49","first-page":"121","article-title":"Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"1","author":"Fan","year":"2007","journal-title":"Lupus"},{"key":"50","first-page":"27","article-title":"Wnt\/beta-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53\/p21 pathway","volume":"38","author":"Cheng","year":"2014","journal-title":"Molecular and cellular biochemistry"},{"key":"51","first-page":"980","article-title":"[Mechanism of umbilical cord mesenchymal stem cells in the upregulation of regulatory T cells by transforming growth factor beta1 in systemic lupus erythematosus]","volume":"9","author":"Sun","year":"2013","journal-title":"Zhonghua yi xue za zhi"},{"key":"52","first-page":"4430","article-title":"Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells","volume":"11","author":"Campbell","year":"2012","journal-title":"Blood"},{"key":"53","first-page":"5012","article-title":"CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4","volume":"17","author":"Liew","year":"2003","journal-title":"Journal of immunology"},{"key":"54","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"3","author":"Mills","year":"2008","journal-title":"European journal of immunology"},{"key":"55","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/eci.12158","article-title":"Immune regulation of bone loss by Th17 cells in oestrogen-deficient osteoporosis","volume":"4","author":"Zhao","year":"2013","journal-title":"European journal of clinical investigation"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.100925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T10:25:09Z","timestamp":1718619909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.100925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,2]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,1]]}},"alternative-id":["100925","27048648"],"URL":"https:\/\/doi.org\/10.18632\/aging.100925","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,2]]}}}